Article
Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome.
Pediatric blood & cancer - 1 Oct 2021
Yanir Asaf D, Krauss Aviva, Stein Jerry, Steinberg-Shemer Orna, Gilad Oded, Lotan Sharon Noy, Dgany Orly, Krasnov Tatyana, Kodman Yona, Feuerstein Tamar, Mardoukh Jacques, Fishman Hila, Geron Ifat, Yacobovich Joanne, Tamary Hannah, Birger Yehudit, Avrahami Galia, Izraeli Shai, Birenboim Shlomit Barzilai
Abstract excerpt
BACKGROUND: Inflammatory manifestations (IM) are well described in adult patients with myelodysplastic syndrome (MDS), but the presentation is highly variable and no standardized treatment exists. This phenomenon is rarely reported in children. As more pediatric patients are hematopoietic stem cell transplantation (HSCT) candidates, the role of anti-inflammatory treatment in relation to HSCT should be defined....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.